ARCHIVES

Recombinant TSH Avoids Need To Stop Replacement Therapy

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

Trimodality Therapy Improves Survival In Early Disease

January 27, 2006

Nutrition Program Announcement Lists Suggested Areas For Research

September 22, 1978

NeoPharm To Begin Phase III Trial For Glioblastoma

December 26, 2003

Bill Clinton Endorses NBCC’s 2020 Goal

January 14, 2011

Research Suggestions Considered By DCBD Diagnostic Group

July 11, 1980

A Take-Home Message From ASCO 2014: NCI-Funded Clinical Research In Jeopardy,bSociety Focuses on Value of NCTN Groups

June 6, 2014